Φορτώνει......
Effect of carvedilol on atrial excitation-contraction coupling, Ca(2+) release, and arrhythmogenicity
Carvedilol is an FDA-approved β-blocker commonly used for treatment of high blood pressure, congestive heart failure, and cardiac tachyarrhythmias, including atrial fibrillation. We investigated at the cellular level the mechanisms through which carvedilol interferes with sarcoplasmic reticulum (SR)...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Physiol Heart Circ Physiol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Physiological Society
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395480/ https://ncbi.nlm.nih.gov/pubmed/32275472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00650.2019 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|